Gogo Inc (NASDAQ:GOGO) had a decrease of 1.61% in short interest. GOGO's SI was 34.18 million shares in October as released by FINRA. Its down …
Source: Google GoGo search
Aimmune Therapeutics (AIMT) “Hold” Rating Reaffirmed by Goldman Sachs; With $27 Target …
Published in GoGo
More from GoGoMore posts in GoGo »
- Brokerages Set <b>Gogo</b> Inc. (NASDAQ:<b>GOGO</b>) Price Target at $15.30 – Defense World
- New York State Teachers Retirement System Has $464000 Holdings in <b>Gogo</b> Inc. (NASDAQ:<b>GOGO</b>)
- Monopoly <b>Go: Go</b> For Gold Gala event milestones, rewards, and more – Sportskeeda
- <b>Go! Go</b>! Loser Ranger Episode 3: Fighter D Accepts Suzukiri's Partnership
- Gordon Keenan Obituary (1948 – 2024) – Struthers, OH – Mahoning Matters – Legacy.com
Be First to Comment